These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3381292)

  • 1. Cyclosporine therapy in chronic inflammatory demyelinating polyradiculoneuropathy--a preliminary report of clinical results in two patients.
    Jongen PJ; Joosten EM; Berden JH; Gabreëls-Festen AA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):329-32. PubMed ID: 3381292
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kolkin S; Nahman NS; Mendell JR
    Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment.
    Dyck PJ; O'Brien PC; Oviatt KF; Dinapoli RP; Daube JR; Bartleson JD; Mokri B; Swift T; Low PA; Windebank AJ
    Ann Neurol; 1982 Feb; 11(2):136-41. PubMed ID: 7041788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine nephrotoxicity without major organ transplantation.
    Nahman NS; Cosio FG; Kolkin S; Mendell JR; Sharma HM
    Ann Intern Med; 1987 Mar; 106(3):400-2. PubMed ID: 3544994
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Drozdowski W; Czerwińska-Ciechan K; Jankowicz E
    Neurol Neurochir Pol; 1994; 28(6):921-6. PubMed ID: 7870266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.
    Hodgkinson SJ; Pollard JD; McLeod JG
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):327-30. PubMed ID: 2341846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant severe psoriasis controlled with systemic cyclosporine therapy.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):58-62. PubMed ID: 3381303
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine.
    Dieterle A; Abeywickrama K; von Graffenried B
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):349-55. PubMed ID: 3381297
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.
    Barnett MH; Pollard JD; Davies L; McLeod JG
    Muscle Nerve; 1998 Apr; 21(4):454-60. PubMed ID: 9533779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine therapy in chronic slowly progressive polymyositis--preliminary report of clinical results in three patients.
    Jongen PJ; Joosten EM; Berden JH; Ter Laak HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):335-9. PubMed ID: 3381294
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of acute inflammatory demyelinating polyradiculoneuropathy relapsed with different clinical features from the first time].
    Konishi T; Horikawa H; Funakawa I; Mano Y; Takayanagi T
    Rinsho Shinkeigaku; 1987 Sep; 27(9):1117-21. PubMed ID: 3440356
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies.
    Bergin PS; Miller DH; Hirsch NP; Murray NM
    Ann Neurol; 1993 Sep; 34(3):406-9. PubMed ID: 8363359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of acquired demyelinating polyradiculoneuropathy.
    Hughes RA
    Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Saito Y; Yokota T
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyradiculoneuropathy: features and prognostic factors with corticosteroid therapy.
    Wertman E; Argov Z; Abrmasky O
    Eur Neurol; 1988; 28(4):199-204. PubMed ID: 3416887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of chronic inflammatory demyelinating polyradiculoneuropathy with diurnal fluctuation of clinical symptoms during administration of prednisolone].
    Nakagawa T; Uchino M; Araki S
    Rinsho Shinkeigaku; 1988 Jun; 28(6):711-4. PubMed ID: 3233844
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.